Roivant Sciences Ltd.
ROIV | NASDAQ
$36.59
-$0.32 (-0.87%)
Nov 2, 2026, 9:58 AM ET · Market open
Fiscal Quarter Period Ending | Q1 2026 Jun 30, 2026 | Q4 2025 Mar 31, 2026 | Q3 2025 Dec 31, 2025 | Q2 2025 Sep 30, 2025 | Q1 2025 Jun 30, 2025 | Q4 2024 Mar 31, 2025 | Q3 2024 Dec 31, 2024 | Q2 2024 Sep 17, 2024 | Q1 2024 Jun 30, 2024 | Q4 2023 Mar 31, 2024 | Q3 2023 Dec 31, 2023 | Q2 2023 Sep 30, 2023 | Q1 2023 Jun 30, 2023 | Q4 2022 Mar 31, 2023 | Q3 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.44M | 2.52M | 2M | 1.57M | 2.17M | 7.57M | 9.02M | 4.48M | 7.99M | 28.93M | 15.56M | 3.65M | 21.62M | 27.38M | 17.05M |
Cost of Revenue | 284K | 320K | 700K | 111K | 154K | 205K | 259K | 234K | 213K | 4.41M | 197K | 223K | 4.21M | 9.39M | 8.32M |
Gross Profit | 1.16M | 2.2M | 1.3M | 1.46M | 2.02M | 7.37M | 8.76M | 4.24M | 7.78M | 24.52M | 15.37M | 3.43M | 17.41M | 17.99M | 8.73M |
Operating Income | -365.99M | -355M | -339.15M | -306.23M | -284.92M | -284.97M | -274.38M | -341.71M | -102.24M | -266M | 5.13B | -213.89M | -276.41M | -234.17M | -280.33M |
Interest Income | 36.92M | 41.18M | 43.27M | 45.34M | 48.32M | 54.62M | 61.85M | 69.77M | 72.13M | 83.46M | 31.95M | 14.3M | 16.72M | 14.28M | 10.25M |
Pretax Income | -294.56M | 454.1M | -290.37M | -159.04M | -269.26M | -203.05M | -234.51M | -224.38M | -19.64M | -191.45M | 5.15B | -241.41M | -326.09M | -179.22M | -382.08M |
Net Income | -189.83M | 302.99M | -265.89M | -113.52M | -223.36M | -206.48M | 169.38M | -230.18M | 95.3M | -151.12M | 5.1B | -304.33M | -291.82M | -33.62M | -352.01M |
Selling & General & Admin | 165.53M | 158.25M | 175.07M | 143.13M | 134.02M | 147.09M | 141.55M | 202.88M | 99.89M | 169.62M | 128.17M | 88.58M | 156.19M | 120.3M | 163.52M |
Research & Development | 202.02M | 198.95M | 165.38M | 164.57M | 152.92M | 145.24M | 141.6M | 143.07M | 120.51M | 120.9M | 108.15M | 114.79M | 125.13M | 131.86M | 125.53M |
Other Expenses | -392K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -110.39M | n/a | -5.35B | 13.95M | 12.5M | n/a | n/a |
Operating Expenses | 367.15M | 357.2M | 340.45M | 307.69M | 286.94M | 292.33M | 283.14M | 345.95M | 110.01M | 290.52M | -5.11B | 217.32M | 293.82M | 252.16M | 289.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.4M | n/a | 9.44M | 9.25M | 8.91M | 8.58M | 8.45M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 367.44M | 357.52M | 341.15M | 307.8M | 287.09M | 292.54M | 283.4M | 346.19M | 110.23M | 294.93M | -5.11B | 217.54M | 298.04M | 261.54M | 297.38M |
Income Tax Expense | -3.96M | 98.35M | 23.33M | 7M | 4.65M | 49.32M | -25.57M | 12.46M | 11.96M | -8.96M | 22.37M | 3.24M | 1.75M | -3.79M | 2.82M |
Shares Outstanding (Basic) | 720.78M | 702.13M | 696.86M | 680.95M | 680.29M | 707.3M | 722.72M | 735.47M | 735.82M | 802.86M | 800.59M | 770.23M | 759.27M | 742.54M | 713.32M |
Shares Outstanding (Diluted) | 720.78M | 812.29M | 696.86M | 680.95M | 680.29M | 707.3M | 722.72M | 735.47M | 781.63M | 802.86M | 844.46M | 770.23M | 759.27M | 742.54M | 713.32M |
EPS (Basic) | -0.26 | 0.43 | -0.38 | -0.17 | -0.33 | -0.29 | 0.23 | -0.31 | 0.13 | -0.19 | 6.37 | -0.40 | -0.38 | -0.05 | -0.49 |
EPS (Diluted) | -0.26 | 0.37 | -0.38 | -0.17 | -0.33 | -0.29 | 0.23 | -0.31 | 0.12 | -0.19 | 6.03 | -0.40 | -0.38 | -0.05 | -0.49 |
EBITDA | -288.27M | 454.74M | -289.68M | -158.12M | -268.16M | -201.63M | -231.59M | -219.54M | -207.74M | -179.05M | -215.57M | -194.35M | -311.34M | -163.13M | -366.67M |
EBIT | -294.56M | 454.1M | -290.37M | -159.04M | -269.26M | -203.05M | -234.51M | -224.38M | -212.62M | -184.28M | -220.96M | -199.94M | -317.18M | -170.64M | -373.63M |
Depreciation & Amortization | 6.29M | 638K | 691K | 921K | 1.1M | 1.43M | 2.92M | 4.84M | 4.88M | 5.23M | 5.39M | 5.59M | 5.84M | 7.51M | 6.97M |
Add to Watchlist
Select watchlists to add or remove ROIV